News Releases

---

Enochian Biosciences, A Company Focused on Gene-Modified Cellular Therapy in Infectious Disease and Cancer, Announces the Appointment of Two Board Members

 January 8, 2020

---

Enochian Biosciences Announces Scientific Presentation of a Novel Approach to Potentially Cure Hepatitis B Virus

 December 10, 2019

---

Enochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel Hepatitis B Virus Treatment

 November 25, 2019

---

Enochian BioSciences Inventor Named to Two Important Scientific Committees

 June 3, 2019

---

Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair

 January 7, 2019

---

Enochian Biosciences Announces Uplisting to NASDAQ Under Symbol “ENOB”

 December 5, 2018

---

Enochian Biosciences Attending 60th ASH on Nov 30-Dec 4 in San Diego, CA

 November 27, 2018

---

Enochian Biosciences to Present at Biotech Showcase 2019

 November 23, 2018

---

Enochian Biosciences Attending Cell & Gene Meeting on the Mesa on October 3-5, 2018 in La Jolla, California.

 September 4, 2018

---

Enochian Biosciences Announces Appointment of Dr. David Hardy to Scientific Advisory Board

 July 3, 2018

---

Dandrit Biotech announces filing of listing application to the Nasdaq capital market

 February 23, 2018

---

Dandrit Biotech announces completion of the acquisition of Enochian

 February 20, 2018